Cell Therapy Market Size, Share & Industry Analysis by Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer (NK) Cells, and Others), By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, and Others), By Indication (Oncology and Others), By End User (Hospitals & Clinics, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 40.15% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Therapy Type

·         CAR-T Cell Therapy

·         TCR-T Cell Therapy

·         Natural Killer (NK) Cells

·         Others

By Product

·         Kymriah

·         Yescarta

·         Tecartus

·         Breyanzi

·         Abecma

·         Carvykti

·         Others

By Indication

·         Oncology

·         Others

By End User

·         Hospitals & Clinics

·         Specialty Clinics

·         Others

By Geography

·         North America (By Therapy Type, Product, Indication, End User, and Country)

o   U.S.

o   Canada

·         Europe (By Therapy Type, Product, Indication, End User, and Country/Sub-region)

o   Germany

o   U.K.

o   France

o   Spain

o   Italy

o   Scandinavia

o   Rest of Europe

·         Asia Pacific (By Therapy Type, Product, Indication, End User, and Country/Sub-region)

o   China

o   Japan

o   India

o   Australia

o   Southeast Asia

o   Rest of Asia Pacific

·         Latin America (By Therapy Type, Product, Indication, End User, and Country/Sub-region)

o   Brazil

o   Mexico

o   Rest of Latin America

·         Middle East & Africa (By Therapy Type, Product, Indication, End User, and Country/Sub-region)

o   GCC

o   South Africa

·         Rest of the Middle East & Africa